Community Health Systems CYH Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $12.49B-1.2% | $12.64B+1.2% | $12.49B+2.3% | $12.21B-1.3% | ||
| $1.86B-4.2% | $1.95B-2.4% | $1.99B+0.9% | $1.98B-3.2% | ||
| $10.62B-0.6% | $10.69B+1.8% | $10.5B+2.5% | $10.24B-0.9% | ||
| 85.1%+0.5pp | 84.6%+0.6pp | 84%+0.2pp | 83.8%+0.3pp | ||
| $11B-9.1% | $12.09B+4.8% | $11.54B+1.3% | $11.39B+3.9% | ||
| $1.49B+175% | $542M-43.3% | $956M+16.3% | $822M-41.5% | ||
| 11.9%+7.6pp | 4.3%-3.4pp | 7.7%+0.9pp | 6.7%-4.6pp | ||
| $872M+1.2% | $862M+3.6% | $832M+197% | -$858M-90.2% | ||
| -$173M+8.0% | -$188M-3.9% | -$181M— | —— | ||
| $724M— | —— | $206M-41.1% | $350M-30.0% | ||
| $48M-40.0% | $80M-57.9% | $190M— | —— | ||
| $509M+199% | -$515M-448% | -$94M-304% | $46M-80.1% | ||
| 4.1%+8.2pp | -4.1%-3.3pp | -0.8%-1.1pp | 0.4%-1.5pp | ||
| $3.75+196% | -$3.89— | —— | $0.36-79.3% | ||
| $1.92B+86.4% | $1.03B-29.6% | $1.46B+7.7% | $1.36B-30.2% | ||
| 15.3%+7.2pp | 8.1%-3.6pp | 11.7%+0.6pp | 11.1%-4.6pp | ||
| $1.49B+175% | $542M-43.3% | $956M+16.3% | $822M-41.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Community Health Systems's revenue?
- Community Health Systems (CYH) generated $12.3B in revenue over the trailing twelve months, down 2.9% year over year.
- Is Community Health Systems profitable?
- Community Health Systems reported $464.0M in net income over the trailing twelve months, a 3.8% net margin.
- What are Community Health Systems's profit margins?
- Gross margin is 85.2% and operating margin is 12.1%, with a 3.8% net margin.
- What is Community Health Systems's earnings per share?
- Community Health Systems's diluted EPS over the trailing twelve months is $3.42.
- Where does Community Health Systems's income statement data come from?
- Every line is extracted from Community Health Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
